INTRAOCULAR LYMPHOMA
Clinical trials for INTRAOCULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAOCULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for INTRAOCULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target cancer in groundbreaking lymphoma trial
Disease control OngoingThis early-phase study is testing a new type of cell therapy for patients with high-risk or returning B-cell non-Hodgkin lymphoma. After receiving a stem cell transplant, patients get an infusion of their own immune cells that have been genetically modified in a lab to better fin…
Matched conditions: INTRAOCULAR LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New strategy aims to tame dangerous virus after cancer transplant
Disease control OngoingThis study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…
Matched conditions: INTRAOCULAR LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Singapore eye center maps inflammatory diseases to improve care
Knowledge-focused OngoingThis study looks back at the medical records of 200 patients treated for various eye inflammation conditions at the Singapore National Eye Centre. Researchers aim to understand who gets these diseases, what treatments they received, and how they fared. The goal is to use this inf…
Matched conditions: INTRAOCULAR LYMPHOMA
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC